Share this post on:

Name :
KIF18A Polyclonal Antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
Polyclonal antibody to KIF18A

Tested applications :
WB

Species reactivity :
Human

Alternative names :
KIF18A antibody; MS-KIF18A antibody; PPP1R99 antibody; kinesin family member 18A antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
Antigen: A synthetic Peptide of human KIF18A

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide, pH7.3.

Storage instructions :
Store at 4℃. Avoid freeze / thaw cycles.

Applications :
WB 1:500 – 1:1000

Background :
Microtubule-depolymerizing kinesin which plays a role in chromosome congression by reducing the amplitude of preanaphase oscillations and slowing poleward movement during anaphase, thus suppressing chromosome movements. May stabilize the CENPE-BUB1B complex at the kinetochores during early mitosis and maintains CENPE levels at kinetochores during chromosome congression.

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CCR2 Antibody
FosB Antibody
FKBP52 Antibody: FKBP52 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to FKBP52. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Gardos- Channel